Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Search

Top

Elusys Therapeutics, Inc. NJ 07054-4612 USA

UEI: SLED_45795CA374087140

Elusys Therapeutics, Inc. NJ 07054-4612 USA is a federal contractor, registered under UEI SLED_45795CA374087140. It has been awarded $80,864,000 in federal contracts. Primary work spans Pharmaceutical Preparation Manufacturing. Top awarding agencies include Department Of Health And Human Services.

Contact Information

Registration and classification details

Registration

UEI Code

SLED_45795CA374087140

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Elusys Therapeutics, Inc. specializes in the manufacture of pharmaceutical products. Their technical expertise includes the production of medical countermeasures and therapeutic agents designed for government stockpiling and emergency preparedness. The company works with the Department of Health an...

Key Performance Metrics

Awards Count

1

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Health And Human Services$80.9M100%

Awards by NAICS

325412 - Pharmaceutical Preparation Manufacturing$80.9M100%

Awards by Agency Over Time

Awards by Place of Performance

Compete with Elusys Therapeutics, Inc. NJ 07054-4612 USA

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for Elusys Therapeutics, Inc. NJ 07054-4612 USA

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Join 750+ contractors already using CLEATUS

Open opportunities in Elusys Therapeutics, Inc. NJ 07054-4612 USA's top NAICS codes and agencies

6505--Sources Sought Notice - Ga68 Dotatate (NETSPOT)

Solicitation # 36C25727Q0060

The Department of Veterans Affairs, Network Contracting Office 17, has issued a Sources Sought Notice under solicitation number 36C25727Q0060 to identify capable firms for the procurement of NETSPOT Gallium Ga 68 Dotatate Injection. This radiopharmaceutical item is to be delivered to the VA North Texas Health Care System located at 4500 S. Lancaster Rd., Dallas, TX 75216-7167. The procurement falls under NAICS code 325412. This notice is intended for information and planning purposes only and does not constitute a formal request for quotes or proposals, nor will a contract be awarded directly from this notice. Interested firms must respond to the primary point of contact, Vance Farrell, by October 30, 2026, at 5:01 PM. Responses must include the company name and are encouraged to include a capabilities statement to demonstrate the firm's ability to provide the required medical item.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

Supply of Adhesive Rubber Tape (NSN 9320016480281)This subcontract involves the supply of adhesive rubber tape to prime contractors supporting the Defense Logistics Agency under the Department of Defense. The contractor is responsible for sourcing or manufacturing tape that matches NSN 9320016480281, ensuring the product is packaged in boxes and accompanied by a Safety Data Sheet compliant with Federal Standard No. 313 and 29 CFR 1910.1200(g). The total delivery requirement is 2,000 boxes of adhesive rubber tape, with the place of performance located at Robins AFB. This procurement falls under NAICS code 325412 and was posted on October 22, 2026, with a response deadline of November 2, 2026.

Defense Logistics Agency

POSTED

DEADLINE

Supply of Povidone-Iodine Topical Solution, USPThis subcontract involves the procurement and delivery of Povidone-Iodine Topical Solution, USP, to support prime contractors fulfilling DLA Troop Support medical supply contracts. The supplier is responsible for providing pharmaceutical solutions that adhere to USP standards and meet the specific requirements of NSN 6505009143593. All shipments must be delivered FOB Destination, with strict adherence to RP001 palletization guidelines and MIL-STD-129 marking and labeling standards. Managed by the Department of Defense under the Medical Supply Chain Pharm FSA, the contract falls under NAICS code 325412. The designated place of performance is Fort Campbell, Kentucky. Interested parties should note the response deadline of October 28, 2026, for this medical supply requirement.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Hydrogen Peroxide Topical SolutionThis subcontract involves the supply of 3% Stabilized Hydrogen Peroxide topical solution to prime contractors supporting Department of Defense medical supply contracts through the Medical Supply Chain Pharm FSA. The requirement is for 2,000 bottles of 16oz solution, each with a 473ml volume and a minimum shelf life of 24 months. All products must adhere to USP standards and Medical Marking Standard No. 1 to ensure pharmaceutical quality and consistency. Performance will take place at Fort Campbell, with strict adherence to packaging and labeling regulations including 49 CFR, 29 CFR, ICAO, and IMDG Annex 1. The opportunity is categorized under NAICS code 325412, with a response deadline set for October 28, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Manufacturing of Witch Hazel Glycerin Impregnated PadsThis subcontract involves the manufacture and supply of finished jars of witch hazel glycerin impregnated pads for prime contractors supporting DLA Troop Support Medical Supply Chain projects. The pads must be fabricated from a blend of 70 percent cotton and 30 percent synthetic non-toxic fiber and impregnated with a solution of purified water, methylparaben, and benzalkonium chloride, maintaining a pH level between 4.2 and 4.8. All materials used must be USP grade, and the final product must comply with Medical Marking Standard No. 1. The contract requires the delivery of 165 jars FOB Germany, with performance taking place in APO 09227-0000. This effort is managed under the Department of Defense for the Medical Supply Chain MD Surg FSF.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Sterile Surgical Lubricant Supply (NSN 6505016265774)This subcontract involves the supply of sterile, bacteriostatic, latex-free, and water-soluble surgical lubricant jelly for prime contractors supporting DLA Troop Support Medical Supply Chain projects. The required product, identified as NSN 6505016265774, must be manufactured in 2.7g foil packets with a minimum shelf life of 36 months. To ensure product integrity, manufacturing must occur in sterile environments, and storage must be strictly maintained at temperatures between 20 and 25 degrees Celsius. The contract mandates full compliance with MIL-STD-2073-1E and Medical Marking Standard No. 1. Managed under NAICS code 325412 for the Department of Defense, the performance of this contract is centered in APO 96260-5479. Interested parties must adhere to the specified response deadline of October 28, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Benzonatate Capsule ManufacturingThis subcontract involves the manufacture and supply of 100 mg Benzonatate Capsules, USP, for prime contractors supporting Department of Defense supply contracts through the Medical Supply Chain Pharm FSA. The scope of work includes the formulation and encapsulation of the active ingredient according to USP standards, with final products delivered in 100 count bottles. All packaging must adhere to Medical Marking Standard No. 1 and MIL-STD-2073-1E. To qualify, the provider must operate out of an FDA-approved facility and maintain strict cGMP compliance. The performance of this contract is centered at Fort Campbell, Kentucky. Interested parties should note the response deadline of October 28, 2026, for this pharmaceutical manufacturing requirement under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Electrical Insulation Tape SupplierThis subcontract involves the supply of white electrical insulation tape for prime contractors supporting the Department of Defense DLA Weapons Support Maritime Supply Chain. The supplier is responsible for manufacturing or sourcing ten rolls of tape that conform to Basic CID A-A-59770A with specific dimensions of 2160 inches in length, 0.750 inches in width, and 0.0070 inches in thickness. Strict compliance is required for marking and packaging according to MIL-STD-129R(3) and MIL-STD-2073-1E standards. Additionally, the materials must be mercury-free and include a certification ensuring a minimum shelf-life of 18 months. The opportunity was posted on October 22, 2026, with a response deadline of October 27, 2026, and performance is centered in zip code 84056-5713.

DLA WEAPONS SUPPORT MARITIME SUPPLY CHAIN ESOC BUYS

POSTED

DEADLINE

Docusate Sodium Capsules (USP, RX Only) SupplierThis subcontract opportunity is for the supply of pharmaceutical-grade Docusate Sodium Capsules to support prime contractors on DLA Troop Support Medical Supply Chain Pharm FSA projects. The selected supplier must manufacture or source 10 mg unit dose capsules that meet USP standards and RX Only compliance, ensuring a minimum shelf life of 36 months. The contract requires the delivery of 1,000 packages, with each package containing 100 capsules. To be eligible, suppliers must utilize FDA-approved manufacturing facilities and strictly adhere to the Buy American Act and the Berry Amendment. The performance of this contract is centered at Fort Campbell, Kentucky. Interested parties should note the response deadline of October 28, 2026, for this Department of Defense requirement under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

POVIDONE-IODINE TOP

Solicitation # SPE2DP-27-T-0143

Solicitation SPE2DP-27-T-0143 is a federal procurement issued by the DLA Troop Support Medical Supply Chain Pharm FSA for Povidone-Iodine Topical Solution, USP (NSN 6505009143593). The requirement is for one package (PG), consisting of 50 bottles of 10 percent solution in 1/2 fl oz (15 ml) containers. This is a critical application item regulated by the FDA, with a total shelf life of 36 months, requiring at least 31 months of remaining shelf life upon delivery to the first government activity. The delivery is specified as FOB Destination to Fort Campbell, Kentucky, with a required delivery date of October 23, 2026, and a delivery window of 20 days. The contract mandates strict adherence to Medical Marking Standard No. 1 and DLA Master List Technical and Quality Requirements, specifically RP001 and RA001, which take precedence over ASTM D3951. Packaging must be commercial and sealed to prevent damage, with hazardous materials requiring compliance with FED-STD-313 and TQ requirement IP025. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with various FAR and DFARS clauses, including the Buy American and Balance of Payments Program and NIST SP 800-171 assessment requirements. This solicitation is not a small business set-aside.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BENZONATATE CAPSULES

Solicitation # SPE2DP-27-T-0148

Solicitation SPE2DP-27-T-0148 is a request for quotations from the Defense Logistics Agency for the procurement of Benzonatate Capsules, USP, 100 mg, in bottles of 100 units. This FDA-regulated drug must be delivered FOB Destination to Fort Stewart, GA, within 20 days after the order is placed. The item is subject to a non-extendable shelf life of 36 months and requires strict environmental controls, including protection from light, moisture, and humidity, and storage at a controlled room temperature between 20 and 25 degrees Celsius. The contract mandates compliance with several technical and quality standards, including MIL-STD-2073-1E for preservation and packing, and Medical Marking Standard No. 1 for labeling. Packaging must consist of suitable sealed unit containers and commercial exterior shipping containers to prevent damage. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and adherence to the Buy American Act and Berry Amendment. The procurement is categorized under NAICS code 325412 and requires the safeguarding of covered defense information per DFARS 252.204-7012.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

HYDROGEN PEROXIDE TOPI

Solicitation # SPE2DP-27-T-0145

Solicitation SPE2DP-27-T-0145 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Hydrogen Peroxide Topical Solution, USP. The requirement is for two bottles, each containing 473 milliliters (16 fluid ounces) of stabilized 3% hydrogen peroxide, identified by NSN 6505-00-153-8480. This over-the-counter drug is regulated by the FDA and is intended for external topical use only. Delivery is required within 20 days after receipt of order to Fort Campbell, Kentucky, with shipping to be handled via the fastest traceable means. The contract mandates strict adherence to hazardous materials regulations, including 49 CFR and International Civil Aviation Organization standards. Contractors must provide a current Material Safety Data Sheet with each shipment and ensure all packaging and labeling comply with the Hazard Communication Standard and Medical Marking Standard No. 1. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with various FAR and DFARS clauses regarding cybersecurity, equal opportunity, and the Buy American Act. This is not a small business set-aside, although a HUBZone price evaluation preference may be applied.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

DOCUSATE SODIUM CAPSUL

Solicitation # SPE2DP-27-T-0146

Solicitation SPE2DP-27-T-0146, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is for the procurement of Docusate Sodium Capsules, USP, RX Only. The requirement consists of one package containing 100 unit doses of 10 mg capsules. The product is regulated by the FDA and must be stored at a controlled room temperature between 20 and 25 degrees Celsius. This item is classified as a Type I Code Q item with a non-extendable shelf life of 36 months. Delivery is required within 20 days after receipt of order to Fort Campbell, Kentucky, with FOB, inspection, and acceptance all set at the destination. Packaging must comply with MIL-STD-2073-1E and Special Packaging Instructions MPW00O001, utilizing suitable sealed unit containers and commercial exterior shipping containers. Marking must adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The solicitation is not a small business set-aside and requires quotes to be submitted via the DLA Internet Bid Board System. Key regulatory requirements include compliance with the Buy American Act, the Berry Amendment, and DFARS 252.204-7012 for safeguarding covered defense information. Invoicing and payment must be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

RINGER'S INJECTION, LAC

Solicitation # SPE2DP-27-T-0144

Solicitation SPE2DP-27-T-0144, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is for the procurement of Ringer's Injection, Lactated, USP. The requirement is for 500 ML units packaged in quantities of 24 per package, with a total order of one package. This FDA-regulated drug must be stored at a controlled room temperature of 25 degrees Celsius and kept away from excessive heat. The product has a total shelf life of 18 months, and a minimum of 15 months of shelf life must remain at the time of delivery to the first government activity. Delivery is required within 20 days after receipt of order, with FOB, inspection, and acceptance all set at the destination in Fort Bragg, North Carolina. Packaging must be commercial and comply with MIL-STD-2073-1E and Special Packaging Instructions MPWND00001, while marking must adhere to Medical Marking Standard No. 1. The contract incorporates various FAR and DFARS clauses, including requirements for Wide Area Workflow invoicing, safeguarding covered defense information, and compliance with the Buy American Act. This is not a small business set-aside, and all quotes must be submitted via the DLA Internet Bid Board System.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Manufacturing (Sacubitril-Valsartan)This subcontract involves the pharmaceutical manufacturing of Sacubitril-Valsartan tablets to support prime contractors on Department of Veterans Affairs procurement projects. The scope of work encompasses the complete production process, including the measuring, weighing, mixing, and formulating of active pharmaceutical ingredients into final tablet form. Each finished product must be delivered with a unique 11-digit NDC number. To qualify, the manufacturer must operate FDA-registered pharmaceutical grade facilities and maintain strict compliance with Current Good Manufacturing Practices. This opportunity is categorized under NAICS code 325412 and is managed through Nac Pharmaceuticals for the Department of Veterans Affairs.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

Brake Shoe Manufacturing and Supply (Critical Application)This subcontract involves the manufacture and supply of 171 units of Brake, Shoe Type (NSN 2530007307620) for prime contractors supporting DLA Weapons Support Land Supply Chain contracts. The manufacturer must strictly adhere to Technical Data Packages and engineering drawings for part numbers 8336701, 8733901, and 8733932, utilizing tooling that meets NR 19207 series specifications. The contract mandates rigorous compliance with Critical Application Item quality standards, as well as DFARS and DLAD regulations. This procurement is categorized under NAICS code 325412 and is managed by the Department of Defense.

DLA WEAPONS SUPPORT LAND SUPPLY CHAIN

POSTED

DEADLINE

Target Protein Synthesis and SupplyThe Target Protein Synthesis and Supply subcontract supports DARPA biochemical projects by providing prime contractors with a diverse panel of synthesized proteins. The scope of work includes the production of proteins with varying structures and functions, with a specific focus on synthesizing difficult-to-purify proteins required for Phase 2 testing. To achieve this, the provider utilizes recombinant DNA technology, protein expression systems, and bioreactors to deliver either crude or purified protein samples and feedstocks. Quality assurance is a central component of the agreement, requiring the provision of a Certificate of Analysis to verify the purity and bioactivity of all delivered materials. This effort falls under NAICS code 325412 and is managed under the Department of Defense through the Defense Advanced Research Projects Agency.

Defense Advanced Research Projects Agcy

POSTED

DEADLINE

6505--Sacubitril/Valsartan Tablets (VA-27-00014055)

Solicitation # 36E79727R0007

The Department of Veterans Affairs Enterprise Procurement Office intends to award a single, unrestricted national mandatory requirements contract for an uninterrupted source of supply of Sacubitril-Valsartan Tablets. This procurement, issued under NAICS code 325412 and FAR Part 12, supports multiple federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will span a one-year base period with four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, requiring the contractor to execute necessary chargeback agreements to ensure timely delivery. The successful offeror must provide a unique eleven-digit National Drug Code (NDC) where the first five digits identify the offeror, and this must be the only label on the product. Strict packaging specifications are required for 60 and 180 count bottles, including a minimum volume of 120cc, a cylindrical body with at least a 5.75 inch circumference, and a safety cap that is either convertible or deshellable. Bottles must accommodate a 5.25 by 2 inch label with an additional 0.5 inch of space for barcodes and expiration data. Offerors who are not the manufacturer must provide a letter of commitment ensuring a sufficient source of supply. The solicitation is expected to be issued around December 18, 2026, with a tentative closing date of January 7, 2027.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE